Trinity Biotech plc (TRIB)
NASDAQ: TRIB · IEX Real-Time Price · USD
1.750
-0.080 (-4.37%)
At close: May 1, 2024, 3:59 PM
1.770
+0.020 (1.14%)
After-hours: May 1, 2024, 7:07 PM EDT
Trinity Biotech Revenue
In the year 2023, Trinity Biotech had annual revenue of $56.83M, a decrease of -9.10%. Revenue in the quarter ending December 31, 2023 was $13.43M, a -14.61% decrease year-over-year.
Revenue (ttm)
$56.83M
Revenue Growth
-9.10%
P/S Ratio
0.24
Revenue / Employee
$142,794
Employees
398
Market Cap
13.37M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 56.83M | -5.69M | -9.10% |
Dec 31, 2022 | 62.52M | -18.63M | -22.96% |
Dec 31, 2021 | 81.15M | -20.83M | -20.43% |
Dec 31, 2020 | 101.98M | 11.55M | 12.77% |
Dec 31, 2019 | 90.44M | -6.60M | -6.80% |
Dec 31, 2018 | 97.04M | -2.11M | -2.12% |
Dec 31, 2017 | 99.14M | -471.00K | -0.47% |
Dec 31, 2016 | 99.61M | -584.00K | -0.58% |
Dec 31, 2015 | 100.20M | -4.68M | -4.46% |
Dec 31, 2014 | 104.87M | 13.66M | 14.97% |
Dec 31, 2013 | 91.22M | 8.71M | 10.55% |
Dec 31, 2012 | 82.51M | 4.56M | 5.85% |
Dec 31, 2011 | 77.95M | -11.69M | -13.04% |
Dec 31, 2010 | 89.64M | -36.27M | -28.81% |
Dec 31, 2009 | 125.91M | -14.23M | -10.16% |
Dec 31, 2008 | 140.14M | -3.48M | -2.42% |
Dec 31, 2007 | 143.62M | 24.94M | 21.02% |
Dec 31, 2006 | 118.67M | 20.11M | 20.41% |
Dec 31, 2005 | 98.56M | 18.55M | 23.19% |
Dec 31, 2004 | 80.01M | 14.33M | 21.82% |
Dec 31, 2003 | 65.68M | 13.70M | 26.35% |
Dec 31, 2002 | 51.98M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CareMax | 751.10M |
STRATA Skin Sciences | 33.36M |
BIMI International Medical | 5.85M |
NEXGEL | 4.09M |
OneMedNet | 1.02M |
TRIB News
- 27 days ago - Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates - GlobeNewsWire
- 4 weeks ago - Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results - GlobeNewsWire
- 7 weeks ago - Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule - GlobeNewsWire
- 2 months ago - Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change - GlobeNewsWire
- 2 months ago - Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change - GlobeNewsWire
- 2 months ago - Trinity Biotech to Present at Emerging Growth Conference - GlobeNewsWire
- 3 months ago - Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code - GlobeNewsWire
- 3 months ago - Trinity Biotech Announces Q3 2023 Financial Results & Business Update - GlobeNewsWire